Stockscreener 앱 받기
105.11
0.75%
0.785
시간 외 거래:
105.11
0.005
+0.00%
전일 마감가:
$104.32
열려 있는:
$105
하루 거래량:
528.51K
Relative Volume:
0.56
시가총액:
$6.84B
수익:
$1.54B
순이익/손실:
$233.56M
주가수익비율:
31.22
EPS:
3.3669
순현금흐름:
$348.64M
1주 성능:
-0.83%
1개월 성능:
+0.07%
6개월 성능:
+63.59%
1년 성능:
+41.25%
1일 변동 폭
$103.70
$105.94
1주일 범위
$100.84
$106.98
52주 변동 폭
$47.25
$111.86
Lantheus Holdings Inc Stock (LNTH) Company Profile
명칭
Lantheus Holdings Inc
전화
978 671-8001
주소
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
105.11 | 6.79B | 1.54B | 233.56M | 348.64M | 3.3669 |
TAK
Takeda Pharmaceutical Co Adr
|
16.73 | 52.53B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.11 | 42.94B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.22 | 36.75B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.91 | 31.25B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
529.05 | 22.57B | 3.17B | 1.29B | 1.01B | 27.09 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-12-12 | 업그레이드 | Truist | Hold → Buy |
| 2025-10-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-08-12 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-18 | 개시 | Goldman | Buy |
| 2024-09-03 | 개시 | Redburn Atlantic | Buy |
| 2024-07-10 | 재확인 | JMP Securities | Mkt Outperform |
| 2023-12-18 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | 개시 | TD Cowen | Outperform |
| 2023-09-29 | 개시 | William Blair | Outperform |
| 2023-03-08 | 개시 | JMP Securities | Mkt Outperform |
| 2022-11-30 | 개시 | SVB Leerink | Outperform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-05-09 | 개시 | B. Riley Securities | Buy |
| 2022-04-13 | 개시 | Truist | Buy |
| 2021-02-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-29 | 재개 | Jefferies | Buy |
| 2019-08-16 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-09-23 | 재개 | Credit Suisse | Neutral |
| 2016-02-24 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-12-11 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | 개시 | Credit Suisse | Outperform |
| 2015-07-20 | 개시 | Jefferies | Buy |
| 2015-07-20 | 개시 | RBC Capital Mkts | Outperform |
| 2015-07-20 | 개시 | Robert W. Baird | Outperform |
| 2015-07-20 | 개시 | Wells Fargo | Outperform |
모두보기
Lantheus Holdings Inc 주식(LNTH)의 최신 뉴스
LNTH Maintained by Truist Securities -- Price Target Raised to $125 - GuruFocus
RadioMedix appoints Brian Markison to board of directors By Investing.com - Investing.com South Africa
Lantheus Holdings Is Maintained at Market Outperform by Mizuho - Moomoo
LNTH Maintained by Mizuho -- Price Target Raised to $120 - GuruFocus
3 Reasons to Avoid LNTH and 1 Stock to Buy Instead - Yahoo Finance
Lantheus Holdings Inc (HAM:0L8) Stock Price, Trades & News - GuruFocus
Lantheus Holdings, Inc. (LNTH) Stock Analysis: A 4.44% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Lantheus (LNTH) Q4 2024 earnings summary - Quartr
Lantheus (LNTH) Q3 2025 earnings summary - Quartr
Lantheus (LNTH) M&A Announcement Summary - Quartr
B. Riley Securities Maintains Lantheus(LNTH.US) With Buy Rating, Raises Target Price to $129 - Moomoo
B. Riley Adjusts Price Target on Lantheus Holdings to $129 From $97, Maintains Buy Rating - Moomoo
LNTH Maintained by B. Riley Securities -- Price Target Raised to $129 - GuruFocus
Is Lantheus Holdings Inc (LNTH) Overvalued After 3.2% Rally? GF - GuruFocus
(LNTH) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Lantheus Holdings Inc focuses on diagnostic imaging growth - ad-hoc-news.de
Lantheus Holdings Inc (LNTH) Stock Down 6.4% but Still Overvalued -- GF Score: 82/100 - GuruFocus
Lantheus Holdings stock hits 52-week high at 90.5 USD - Investing.com
Lantheus Q1 2026 slides: regulatory wins fuel growth transition - Investing.com
LNTHLantheus Holdings Inc Latest SEC Filings - Finviz
Did FDA’s Facility-Related LNTH-2501 Delay and Russell Additions Just Reframe Lantheus Holdings’ (LNTH) Risk Profile? - Sahm
LNTH DEADLINEFINAL REMINDER: Bronstein, Gewirtz & Grossman LLC - The National Law Review
Lantheus Holdings Inc focuses on diagnostic imaging and radiopharmaceutical growth - Ad Hoc News
Lantheus receives complete response letter for LNTH-2501 - MSN
Lantheus Holdings stock hits 52-week high at 111.52 USD By Investing.com - Investing.com South Africa
Lantheus Holdings stock hits 52-week high at 111.52 USD - Investing.com
LNTH Reiterated by Citizens -- Price Target Maintained at $115 - GuruFocus
What's Going On With Lantheus Stock Monday?Lantheus Holdings (NASDAQ:LNTH) - Benzinga
Lantheus stock holds at Market Outperform despite FDA setback By Investing.com - Investing.com South Africa
Lantheus stock holds at Market Outperform despite FDA setback - Investing.com
Lantheus Holdings, Inc. (LNTH) Stock Analysis: Strong Buy Ratings Amid Impressive ROE and Expanding Diagnostic Portfolio - DirectorsTalk Interviews
Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday - Benzinga
Lantheus Holdings, Inc.(NasdaqGM: LNTH) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Lantheus Holdings, Inc.(NasdaqGM: LNTH) added to Russell 2000 Defensive Index - marketscreener.com
LNTH SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. C - The National Law Review
Bronstein, Gewirtz & Grossman, LLC (LNTH) Investigation: Bronstei - The National Law Review
LNTH STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Levi & Korsinsky Helps Shareholders SueWallSt After Lantheus Holdings, Inc. Stock Drops - The National Law Review
LNTH INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Liquidity Mapping Around (LNTH) Price Events - Stock Traders Daily
William Blair Maintains Lantheus(LNTH.US) With Buy Rating - Moomoo
FDA issues complete response letter for Lantheus’ NET imaging drug By Investing.com - Investing.com Nigeria
Lantheus (LNTH) Faces FDA Response on LNTH-2501 Application - GuruFocus
Lantheus (LNTH) Faces Setback with FDA Response on LNTH-2501 - GuruFocus
FDA issues complete response letter for Lantheus’ NET imaging drug - Investing.com
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues - Reuters
Lantheus stock falls after FDA rejects drug application By Investing.com - Investing.com South Africa
Lantheus stock falls after FDA rejects drug application - Investing.com
Lantheus Gets FDA Complete Response Letter for LNTH-2501 - Moomoo
Lantheus Application for Tumor Imaging Drug Rejected Due to Manufacturing Concerns - marketscreener.com
Lantheus Holdings Inc (LNTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
1.61%
자본화:
|
볼륨(24시간):